A share price of CVS Health Corp [CVS] is currently trading at $44.25, up 0.25%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The CVS shares have gain 0.29% over the last week, with a monthly amount drifted -23.86%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
CVS Health Corp [NYSE: CVS] stock has seen the most recent analyst activity on December 03, 2024, when Deutsche Bank upgraded its rating to a Buy but kept the price target unchanged to $66 for it. Previously, Wells Fargo upgraded its rating to Overweight on November 18, 2024, and elevated its price target to $66. On October 10, 2024, upgrade upgraded it’s rating to Overweight and revised its price target to $82 on the stock. TD Cowen upgraded its rating to a Buy and increased its price target to $85 on October 04, 2024. Robert W. Baird initiated its recommendation with a Neutral and recommended $61 as its price target on May 30, 2024. TD Cowen downgraded its rating to Hold for this stock on May 07, 2024, and downed its price target to $59. In a note dated May 02, 2024, UBS downgraded an Neutral rating on this stock and revised its target price from $85 to $60.
CVS Health Corp experienced fluctuations in its stock price throughout the past year between $43.56 and $83.25. Currently, Wall Street analysts expect the stock to reach $73.5 within the next 12 months. CVS Health Corp [NYSE: CVS] shares were valued at $44.25 at the most recent close of the market. An investor can expect a potential return of 66.1% based on the average CVS price forecast.
Analyzing the CVS fundamentals
Trailing Twelve Months sales for CVS Health Corp [NYSE:CVS] were 369.15B which represents 6.12% growth. Gross Profit Margin for this corporation currently stands at 0.14% with Operating Profit Margin at 0.03%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.01%. To continue investigating profitability, this company’s Return on Assets is posted at 0.02, Equity is 0.07 and Total Capital is 0.06. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.87.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 43.90 points at the first support level, and at 43.56 for the second support level. However, for the 1st resistance point, the stock is sitting at 44.42, and for the 2nd resistance point, it is at 44.60.
Ratios To Look Out For
To put it in perspective, the Current Ratio for CVS Health Corp [NYSE:CVS] is 0.80. In addition, the Quick Ratio stands at 0.59 and the Cash Ratio stands at 0.08. Considering the valuation of this stock, the price to sales ratio is 0.15, the price to book ratio is 0.74 and price to earnings (TTM) ratio is 11.24.
Transactions by insiders
Recent insider trading involved LUDWIG EDWARD J, Director, that happened on May 02 ’24 when 1000.0 shares were purchased. Director, Mahoney Michael F completed a deal on May 02 ’24 to buy 9181.0 shares. Meanwhile, EVP and Pres-Pharm, Consumer W Shah Prem S sold 29473.0 shares on Feb 16 ’24.
